Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Tebipenem pivoxil

Generic Name: Tebipenem pivoxil

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₁N_₃O_₆S_₂

CAS Number: 161715-24-8

Unique Ingredient Identifier: 95AK1A52I8

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants

Phase 1

Completed

Posted: 2024/12/10

Sponsor:Spero Therapeutics

ID:NCT06727136

A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Phase 3

Recruiting

Posted: 2023/09/29

Sponsor:Spero Therapeutics

ID:NCT06059846

A Study to Compare Two Bioanalytical Assays for Tebipenem

Phase 1

Completed

Posted: 2023/05/12

Sponsor:Spero Therapeutics

ID:NCT05856747

Tebipenem Trial in Children With Shigellosis

Phase 2

Recruiting

Posted: 2021/11/16

Sponsor:International Centre...

ID:NCT05121974

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Phase 1

Completed

Posted: 2021/06/09

Sponsor:Hartford Hospital

ID:NCT04919954

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy